SCHEMBL2750342

SCHEMBL2750342

FC(F)(F)c1ccccc1Oc1cccnn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
HTR1A P08908 1/20 0.42
SLC6A3 Q01959 1/20 0.42
SCD O00767 1/20 0.41
MRGPRX1 Q96LB2 1/20 0.41
P2RY1 P47900 1/20 0.38
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
TSHR P16473 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ADRA2A P08913 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
NOTUM Q6P988 2/20 0.36
LTA4H P09960 1/20 0.36
PTGS2 P35354 1/20 0.36
HSD11B1 P28845 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11784533 0.83 P2RY1 (0.47) P2RY1KMT2AMEN1NPC1TSHR
SCHEMBL19994256 0.79 KDM4E (0.51) SLC6A2SLC6A4HTR1ASLC6A3SCD
SCHEMBL27606810 0.77 MEN1 (0.47) SLC6A2SLC6A4HTR1ASLC6A3MRGPRX1
SCHEMBL4028874 0.75 BCAT2 (0.53) SLC6A2SLC6A4HTR1ASLC6A3MRGPRX1
SCHEMBL10354405 0.75 KMT2A (0.43) SLC6A2SLC6A4HTR1ASLC6A3SCD
SCHEMBL13745350 0.75 KMT2A (0.51) SLC6A2SLC6A4HTR1ASLC6A3SCD
SCHEMBL1685381 0.75 LTA4H (0.46) SLC6A2SLC6A4HTR1ASLC6A3MRGPRX1
SCHEMBL134448 0.74 SMN1; SMN2 (0.69) SLC6A2SLC6A4HTR1AMRGPRX1KMT2A
SCHEMBL29392331 0.74 SMN1; SMN2 (0.69) SLC6A2SLC6A4HTR1AMRGPRX1KMT2A
SCHEMBL27874011 0.74 ALDH1A1 (0.47) SLC6A2SLC6A4HTR1ASLC6A3SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178540-B2 Pyrimidylmethyl-sulfonamide compounds BASF SE (DE) 2012-05-15 US disclosed
US-20100077512-A1 Pyridazin-4-ylmethyl-sulfonamides used as Fungicides and Against Arthropods BASF SE (DE) 2010-03-25 US disclosed
US-20100069243-A1 Pyrimidylmethyl-Sulfonamide Compounds BASF SE (DE) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069243-A1 Pyrimidylmethyl-Sulfonamide Compounds TPMT, NISCH, PPA1 SLC6A2 1558/4885SLC6A4 1639/4885HTR1A 4466/4885
US-20100077512-A1 Pyridazin-4-ylmethyl-sulfonamides used as Fungicides and Against Arthropods PIR, PRDX4, PRDX2 SLC6A2 3403/4885SLC6A4 2531/4885HTR1A 4456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.